We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock
ODT

Delisted

ODT was delisted on the 14th of January, 2022.

Back to rankings

8 hedge funds and large institutions have $7.13M invested in Odonate Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% less capital invested

Capital invested by funds: $32.7M → $7.13M (-$25.6M)

84% less funds holding

Funds holding: 50 → 8 (-42)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 42

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
8
Holders Change
-42
Holders Change %
-84%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
4
Closed
42
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$54K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$17.2M
2
IC
Ikarian Capital
Texas
-$1.81M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.3M
4
BlackRock
BlackRock
New York
-$541K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$505K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
– -$76K -56,182 Closed
Northern Trust
27
Northern Trust
Illinois
– -$74K -54,472 Closed
Point72 Asset Management
28
Point72 Asset Management
Connecticut
– -$68K -50,000 Closed
Group One Trading
29
Group One Trading
Illinois
– -$59K -43,485 Closed
Rafferty Asset Management
30
Rafferty Asset Management
New York
– -$47K -35,099 Closed
OQS
31
Occudo Quantitative Strategies
Florida
– -$33K -24,609 Closed
AC
32
Apogem Capital
New York
– -$31K -22,931 Closed
Charles Schwab
33
Charles Schwab
California
– -$27K -19,636 Closed
EGM
34
Engineers Gate Manager
New York
– -$25K -18,822 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$24K -18,017 Closed
Jane Street
36
Jane Street
New York
– -$19K -13,801 Closed
ECM
37
ExodusPoint Capital Management
New York
– -$16K -12,108 Closed
XT
38
XTX Topco
Cayman Islands
– -$16K -11,714 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$14K -10,397 Closed
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
– -$15K -10,000 Closed
Federated Hermes
41
Federated Hermes
Pennsylvania
– -$6K -4,279 Closed
Fidelity Investments
42
Fidelity Investments
Massachusetts
– -$3K -2,000 Closed
TWC
43
TD Waterhouse Canada
Ontario, Canada
– -$1.82K -1,265 Closed
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
– -$1.33K -989 Closed
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
– -$1K -503 Closed
1
2

ODT Hedge Fund Activity: Q1 2022 in Review

8 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q1 2022, worth a combined $7.13M — down 78% from $32.7M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ODT and 0 opened new positions — a net loss of 42 holders — while 4 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $17.2M sold.

  • 8 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q1 2022, down from 50 in Q4 2021.
  • Funds reported $7.13M of Odonate Therapeutics, Inc. Common Stock stock for Q1 2022, down 78% quarter-over-quarter.
  • 0 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q1 2022 and 42 closed out, a net change of -42 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock seller in Q1 2022 was Tang Capital Management, an estimated $17.2M sold.

Based on aggregated 13F filings for Q1 2022.